Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech
BioCentury This Week
00:00
Navigating the GLP-1 Treatment Landscape
This chapter examines the challenges and complexities pharmaceutical companies face in developing GLP-1 treatments for obesity, drawing parallels to the PD-1 drug scenario. It highlights the growing patient demand and significant manufacturing hurdles while discussing the potential for innovative strategies and partnerships. The role of AI in transforming drug development processes is also explored, emphasizing the importance of data quality and specificity in advancing biopharma.
Transcript
Play full episode
